-
公开(公告)号:US20140171414A1
公开(公告)日:2014-06-19
申请号:US14108904
申请日:2013-12-17
Applicant: CHIESI FARMACEUTICI S.p.A.
Inventor: Lilian ALCARAZ , Robert Andrew Heald , Jonathan Mark Sutton , Elisabetta Armani , Carmelida Capaldi
IPC: C07D487/04 , C07C309/20 , C07C309/29 , C07D453/02 , C07D487/08
CPC classification number: C07D487/04 , A61K9/0053 , A61K9/007 , C07C47/19 , C07C53/06 , C07C309/04 , C07C309/08 , C07C309/20 , C07C309/29 , C07D453/02 , C07D487/08 , C07D519/00
Abstract: Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for treating diseases and conditions in which HNE is implicated.
Abstract translation: 本文定义的式(I)化合物显示人嗜中性粒细胞弹性蛋白酶抑制性质,并且可用于治疗涉及HNE的疾病和病症。
-
公开(公告)号:US09868740B2
公开(公告)日:2018-01-16
申请号:US15317274
申请日:2014-06-12
Applicant: CHIESI FARMACEUTICI S.p.A.
Inventor: Lilian Alcaraz , Robert Andrew Heald , Jonathan Mark Sutton , Elisabetta Armani , Carmelida Capaldi
IPC: C07D487/04 , A61K31/519 , A61P11/06 , A61P11/08 , A61P11/12 , A61P11/00
CPC classification number: C07D487/04
Abstract: This invention relates to heterocyclic compounds, which are pyrimidinone derivatives having human neutrophil elastase inhibitory properties, and their use in therapy.
-
13.Pyrimidinone compounds as human neutrophil elastase inhibitors 有权
Title translation: 嘧啶酮化合物作为人嗜中性粒细胞弹性蛋白酶抑制剂公开(公告)号:US09365577B2
公开(公告)日:2016-06-14
申请号:US14108904
申请日:2013-12-17
Applicant: CHIESI FARMACEUTICI S.p.A.
Inventor: Lilian Alcaraz , Robert Andrew Heald , Jonathan Mark Sutton , Elisabetta Armani , Carmelida Capaldi
IPC: C07D487/04 , A61K31/519 , C07C309/20 , C07C309/29 , C07D453/02 , C07D487/08
CPC classification number: C07D487/04 , A61K9/0053 , A61K9/007 , C07C47/19 , C07C53/06 , C07C309/04 , C07C309/08 , C07C309/20 , C07C309/29 , C07D453/02 , C07D487/08 , C07D519/00
Abstract: Pyrimidinone compounds defined herein exhibit human neutrophil elastase inhibitory properties and are useful for treating diseases and conditions in which HINE is implicated.
Abstract translation: 本文定义的嘧啶酮化合物显示人嗜中性粒细胞弹性蛋白酶抑制性质,并且可用于治疗涉及HINE的疾病和病症。
-
公开(公告)号:US09023855B2
公开(公告)日:2015-05-05
申请号:US14177469
申请日:2014-02-11
Applicant: Chiesi Farmaceutici S.p.A.
Inventor: Toby Jonathan Blench , Christine Edwards , Robert Andrew Heald , Janusz Jozef Kulagowski , Jonathan Mark Sutton , Carmelida Capaldi
IPC: A61K31/519 , C07D487/00 , C07D487/04
CPC classification number: C07D487/04
Abstract: Compounds of formula (I): are useful as inhibitors of human neutrophil elastase.
Abstract translation: 式(I)化合物:可用作人中性粒细胞弹性蛋白酶的抑制剂。
-
公开(公告)号:US20140018345A1
公开(公告)日:2014-01-16
申请号:US13940555
申请日:2013-07-12
Applicant: CHIESI FARMACEUTICI S.p.A.
Inventor: Carmelida Capaldi , Robert Andrew Heald , Nicholas Charles Ray , Jonathan Mark Sutton
IPC: C07D471/04
CPC classification number: C07D471/04
Abstract: Compounds of formula (I): wherein R1, R2, R3, R5, R6, A1, A2, A3, A4 assume meanings as defined in formula (I) are inhibitors of neutrophil elastase.
Abstract translation: 式(I)化合物:其中R 1,R 2,R 3,R 5,R 6,A 1,A 2,A 3,A 4定义为式(I)中定义的含义是嗜中性粒细胞弹性蛋白酶抑制剂。
-
-
-
-